scout
|Videos|February 21, 2017

A Study of Cobimetinib Plus Paclitaxel in TNBC

Adam M. Brufsky, MD, PhD, professor of Medicine, associate chief of Hematology/Oncology, co-director of the Comprehensive Breast Care Center, associate director of Clinical Investigation, University of Pittsburgh, discusses a study of cobimetinib plus paclitaxel in triple-negative breast cancer (TNBC).

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME